Clinical outcome of standardized (177)Lu-PSMA-617 therapy in metastatic prostate cancer patients receiving 7400 MBq every 4 weeks - Rasul, S; Hacker, M; Kretschmer-Chott, E (Eur J Nucl Med Mol Imaging)